$2 Million Revenue, High-Growth Clinical Research Site in Texas
High-Growth Clinical Research Site with 70+ Trial Awards
On NextCompany since August 27, 2026 (48 days)
TX area
Business overview
A clinical research site in Texas supports Phase II through Phase IV pharmaceutical, biotechnology, medical device, and diagnostic trials. The site has received more than 70 trial awards and maintains over 20 active studies. Relationships with more than 15 sponsors and CROs generate a pipeline. Approximately $1.5 million in signed-study revenue is expected over the next 12 months. Ownership seeks a strategic partner for expansion.
Who is a good fit for this business
- Strategic partners who want to scale a clinical research platform with internal patient access fit this site.
- Buyers seeking relationships with over 15 pharmaceutical sponsors and CROs match this opportunity.
- Acquirers looking for $1.5 million in signed-study revenue over the next 12 months align here.
Details
- Reason for selling
- Ownership is seeking a strategic partner to support expansion and scale the platform.
Frequently Asked Questions
The site supports Phase II through Phase IV pharmaceutical, biotechnology, medical device, and diagnostic trials. Over 20 studies remain active currently.
Gross revenue reaches $2,000,000. Approximately $1.5 million of signed-study revenue is expected over the next 12 months. The site operates within a clinical care setting with internally sourced patients.
Ownership seeks a strategic partner to support expansion and scale the platform. Existing staff are expected to stay. The owner will assist with transition and future growth.
The seller lists the site at $6,000,000. The business maintains relationships with more than 15 sponsors and CROs.
The site operates inside a clinical care setting. This structure provides direct access to a high-volume patient population. Most participants are sourced internally.